Skip to content

Clinical trials

Wet Macular Degeneration trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Wet Macular Degeneration Country / region: Canada Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20151
20192
20211
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
4D Molecular Therapeutics1
AbbVie1
Bayer1
Elisigen, Inc.1
Hoffmann-La Roche1
McMaster University1
Novartis Pharmaceuticals1
Opthea Limited1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Wet Macular Degeneration9
Macular Degeneration7
Eye Diseases4
Retinal Degeneration4
Retinal Diseases4
Choroidal Neovascularization3
Vision Disorders3
Geographic Atrophy1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.